메뉴 건너뛰기




Volumn 55, Issue 12, 2010, Pages 3630-3631

A new second-line sequential regimen for helicobacter pylori eradication based on levofloxacin: A pilot study

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; LEVOFLOXACIN; OMEPRAZOLE;

EID: 78649327673     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-010-1199-0     Document Type: Letter
Times cited : (5)

References (7)
  • 1
    • 45549100532 scopus 로고    scopus 로고
    • Meta-analysis: Sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment
    • N Jafri C Hormung C Howden 2008 Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment Ann Intern Med 148 1 9
    • (2008) Ann Intern Med , vol.148 , pp. 1-9
    • Jafri, N.1    Hormung, C.2    Howden, C.3
  • 2
    • 33645556634 scopus 로고    scopus 로고
    • Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: A meta-analysis
    • 1:CAS:528:DC%2BD28XjtlGhsL8%3D 10.1111/j.1572-0241.2006.00637.x 16542284
    • RJ Saad P Schoenfeld HM Kim WD Chey 2006 Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis Am J Gastroenterol 101 488 496 1:CAS:528:DC%2BD28XjtlGhsL8%3D 10.1111/j.1572-0241.2006.00637.x 16542284
    • (2006) Am J Gastroenterol , vol.101 , pp. 488-496
    • Saad, R.J.1    Schoenfeld, P.2    Kim, H.M.3    Chey, W.D.4
  • 3
    • 62149086210 scopus 로고    scopus 로고
    • Meta-analysis: Four-drug, three-antibiotic, non-bismuth-containing "concomitant therapy" versus triple therapy for Helicobacter pylori eradication
    • 1:CAS:528:DC%2BD1MXkvVWmtbg%3D 10.1111/j.1523-5378.2009.00671.x 19298338
    • AS Essa JR Kramer DY Graham G Treiber 2009 Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing "concomitant therapy" versus triple therapy for Helicobacter pylori eradication Helicobacter 14 109 118 1:CAS:528:DC%2BD1MXkvVWmtbg%3D 10.1111/j.1523-5378.2009.00671.x 19298338
    • (2009) Helicobacter , vol.14 , pp. 109-118
    • Essa, A.S.1    Kramer, J.R.2    Graham, D.Y.3    Treiber, G.4
  • 4
    • 70449399157 scopus 로고    scopus 로고
    • The modified sequential treatment regimen containing levofloxacin for Helicobacter pylori eradication in Turkey
    • 1:CAS:528:DC%2BD1MXhsF2hs7%2FO 10.1111/j.1523-5378.2009.00720.x 19889069
    • A Aydin N Oruc I Turan O Ozutemiz M Tuncyurek A Musoglu 2009 The modified sequential treatment regimen containing levofloxacin for Helicobacter pylori eradication in Turkey Helicobacter 14 520 524 1:CAS:528:DC%2BD1MXhsF2hs7%2FO 10.1111/j.1523-5378.2009.00720.x 19889069
    • (2009) Helicobacter , vol.14 , pp. 520-524
    • Aydin, A.1    Oruc, N.2    Turan, I.3    Ozutemiz, O.4    Tuncyurek, M.5    Musoglu, A.6
  • 5
    • 33747336969 scopus 로고    scopus 로고
    • Sequential therapy using high-dose esomeprazole-amoxicillin followed by gatifloxacin for Helicobacter pylori infection
    • 1:CAS:528:DC%2BD28XhtFGqsrjJ 10.1111/j.1365-2036.2006.03072.x 16918889
    • DY Graham S Abudayyeh MT El-Zimaity J Hoffman R Reddy AR Opekun 2006 Sequential therapy using high-dose esomeprazole-amoxicillin followed by gatifloxacin for Helicobacter pylori infection Aliment Pharmacol Ther 24 845 850 1:CAS:528:DC%2BD28XhtFGqsrjJ 10.1111/j.1365-2036.2006.03072.x 16918889
    • (2006) Aliment Pharmacol Ther , vol.24 , pp. 845-850
    • Graham, D.Y.1    Abudayyeh, S.2    El-Zimaity, M.T.3    Hoffman, J.4    Reddy, R.5    Opekun, A.R.6
  • 6
    • 37849047500 scopus 로고    scopus 로고
    • Second-line rescue therapy with levofloxacin after H. pylori treatment failure: A Spanish multicenter study of 300 patients
    • 1:CAS:528:DC%2BD1cXhsVyjt78%3D 17764498
    • JP Gisbert F Bermejo M Castro-Fernandez, et al. 2008 Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients Am J Gastroenterol 103 71 76 1:CAS:528:DC%2BD1cXhsVyjt78%3D 17764498
    • (2008) Am J Gastroenterol , vol.103 , pp. 71-76
    • Gisbert, J.P.1    Bermejo, F.2    Castro-Fernandez, M.3
  • 7
    • 33748263770 scopus 로고    scopus 로고
    • Can Helicobacter pylori eradication regimens be shortened in clinical practice? An open-label, randomized, pilot study of 4 and 7-day triple therapy with rabeprazole, high-dose levofloxacin, and tinidazole
    • 1:CAS:528:DC%2BD28XmsFOnu70%3D 10.1097/00004836-200607000-00010 16825934
    • EG Giannini C Bilardi P Dulbecco, et al. 2006 Can Helicobacter pylori eradication regimens be shortened in clinical practice? An open-label, randomized, pilot study of 4 and 7-day triple therapy with rabeprazole, high-dose levofloxacin, and tinidazole J Clin Gastroenterol 40 515 520 1:CAS:528:DC%2BD28XmsFOnu70%3D 10.1097/00004836-200607000-00010 16825934
    • (2006) J Clin Gastroenterol , vol.40 , pp. 515-520
    • Giannini, E.G.1    Bilardi, C.2    Dulbecco, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.